Tratamiento de las infecciones fúngicas invasoras

Pachón, Jerónimo; Cisneros, José Miguel; Collado-Romacho, Antonio Ramón; Lomas-Cabezas, J.M.; León-Naranjo, Fernando Lozano de; Parra-Ruiz, Jorge; Rivero-Román, Antonio

doi:10.1016/s0213-005x(06)73772-7

Cited by 9 publications

(2 citation statements)

References 96 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… 198 In case of infection control and as long as the patient continues receiving antifungal drugs, there are no contraindications for starting a new cycle of chemotherapy or for the transplantation of hematopoietic stem cells (B-II). 199 , 200 …”

Section: Treatmentmentioning

confidence: 99%

Brazilian guidelines for the management of candidiasis – a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical

Colombo

Guimarães

Camargo

et al. 2013

The Brazilian Journal of Infectious Diseases

115

View full text Add to dashboard Cite

Candida infections account for 80% of all fungal infections in the hospital environment, including bloodstream, urinary tract and surgical site infections. Bloodstream infections are now a major challenge for tertiary hospitals worldwide due to their high prevalence and mortality rates. The incidence of candidemia in tertiary public hospitals in Brazil is approximately 2.5 cases per 1000 hospital admissions. Due to the importance of this infection, the authors provide a review of the diversity of the genus Candida and its clinical relevance, the therapeutic options and discuss the treatment of major infections caused by Candida. Each topography is discussed with regard to epidemiological, clinical and laboratory diagnostic and therapeutic recommendations based on levels of evidence.

show abstract

Section: Treatmentmentioning

confidence: 99%

Brazilian guidelines for the management of candidiasis – a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical

Colombo

Guimarães

Camargo

et al. 2013

The Brazilian Journal of Infectious Diseases

115

View full text Add to dashboard Cite

show abstract

“…den resumirse en los siguientes aspectos: a) la publicación de numerosas recomendaciones [43][44][45][46] , que detallan las opciones de antifúngicos de primera elección y sus alternativas para cada situación y entidad, a las que remitimos al lector para su valoración personal; b) la duración no claramente establecida del tratamiento de la candidemia y su posible relación con el desarrollo de complicaciones metastásicas tardías; c) el papel de los nuevos antifúngicos, especialmente los nuevos azoles y las equinocandinas, basándose en los estudios de sensibilidad in vitro de aislamientos de Candida 47 y en la experiencia clínica acumulada 48,49 , y d) el conocimiento experimental que fundamenta el papel a desempeñar en el futuro el tratamiento antifúngico combinado. La duración óptima del tratamiento antifúngico de la candidemia es desconocida.…”

Section: Repercusión Terapéuticaunclassified